IL-1/TNF-.alpha.-activated kinase (ITAK), and methods of making and using the same
US6080557A · kind A · utility
6Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 1997 |
| Grant date | Jun 27, 2000 |
| Priority date | — |
| Expiry date | Jun 6, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N9/1205
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Purified and isolated IL-1/TNF-.alpha.-activated kinase (ITAK), nucleic acids encoding ITAK, processes for production of recombinant forms of ITAK, pharmaceutical compositions containing ITAK, and use of ITAK in therapies and in various assays, including assays to detect antagonists and agonists of ITAK are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.